Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism - PubMed (original) (raw)

. 2003 Apr 18;278(16):13775-83.

doi: 10.1074/jbc.M212262200. Epub 2003 Feb 3.

Affiliations

• PMID: 12566438
• DOI: 10.1074/jbc.M212262200

Free article

Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism

Norma Marchesini et al. J Biol Chem. 2003.

Free article

Abstract

Neutral sphingomyelinase (N-SMase) is one of the key enzymes involved in the generation of ceramide; however, the gene(s) encoding for the mammalian N-SMase is still not well defined. Previous studies on the cloned nSMase1 had shown that the protein acts primarily as lyso-platelet-activating factor-phospholipase C. Recently the cloning of another putative N-SMase, nSMase2, was reported. In this study, biochemical characterization of the mouse nSMase2 was carried out using the overexpressed protein in yeast cells in which the inositol phosphosphingolipid phospholipase C (Isc1p) was deleted. N-SMase activity was dependent on Mg(2+) and was activated by phosphatidylserine and inhibited by GW4869. The ability of nSMase2 to recognize endogenous sphingomyelin (SM) as substrate was investigated by overexpressing nSMase2 in MCF7 cells. Mass measurements showed a 40% decrease in the SM levels in the overexpressor cells, and labeling studies demonstrated that nSMase2 accelerated SM catabolism. Accordingly, ceramide measurement showed a 60 +/- 15% increase in nSMase2-overexpressing cells compared with the vector-transfected MCF7. The role of nSMase2 in cell growth was next investigated. Stable overexpression of nSMase2 resulted in a 30-40% decrease in the rate of growth at the late exponential phase. Moreover, tumor necrosis factor induced approximately 50% activation of nSMase2 in MCF7 cells overexpressing the enzyme, demonstrating that nSMase2 is a tumor necrosis factor-responsive enzyme. In conclusion, these results 1) show that nSMase2 is a structural gene for nSMase, 2) suggest that nSMase2 acts as a bona fide N-SMase in cells, and 3) implicate nSMase2 in the regulation of cell growth and cell signaling.

PubMed Disclaimer

Similar articles

• Identification of ISC1 (YER019w) as inositol phosphosphingolipid phospholipase C in Saccharomyces cerevisiae.
  Sawai H, Okamoto Y, Luberto C, Mao C, Bielawska A, Domae N, Hannun YA. Sawai H, et al. J Biol Chem. 2000 Dec 15;275(50):39793-8. doi: 10.1074/jbc.M007721200. J Biol Chem. 2000. PMID: 11006294
• Neutral sphingomyelinase 2 (nSMase2) is the primary neutral sphingomyelinase isoform activated by tumour necrosis factor-α in MCF-7 cells.
  Clarke CJ, Cloessner EA, Roddy PL, Hannun YA. Clarke CJ, et al. Biochem J. 2011 Apr 15;435(2):381-90. doi: 10.1042/BJ20101752. Biochem J. 2011. PMID: 21303347 Free PMC article.
• Role for mammalian neutral sphingomyelinase 2 in confluence-induced growth arrest of MCF7 cells.
  Marchesini N, Osta W, Bielawski J, Luberto C, Obeid LM, Hannun YA. Marchesini N, et al. J Biol Chem. 2004 Jun 11;279(24):25101-11. doi: 10.1074/jbc.M313662200. Epub 2004 Mar 29. J Biol Chem. 2004. PMID: 15051724
• Thematic review series: sphingolipids. ISC1 (inositol phosphosphingolipid-phospholipase C), the yeast homologue of neutral sphingomyelinases.
  Matmati N, Hannun YA. Matmati N, et al. J Lipid Res. 2008 May;49(5):922-8. doi: 10.1194/jlr.R800004-JLR200. Epub 2008 Feb 27. J Lipid Res. 2008. PMID: 18305313 Free PMC article. Review.
• Mammalian neutral sphingomyelinases: regulation and roles in cell signaling responses.
  Wu BX, Clarke CJ, Hannun YA. Wu BX, et al. Neuromolecular Med. 2010 Dec;12(4):320-30. doi: 10.1007/s12017-010-8120-z. Epub 2010 Jun 16. Neuromolecular Med. 2010. PMID: 20552297 Free PMC article. Review.

Cited by

• Novel chemotherapeutic drugs in sphingolipid cancer research.
  Canals D, Hannun YA. Canals D, et al. Handb Exp Pharmacol. 2013;(215):211-38. doi: 10.1007/978-3-7091-1368-4_12. Handb Exp Pharmacol. 2013. PMID: 23579458 Free PMC article. Review.
• Intercellular transfer of miR-200c-3p impairs the angiogenic capacity of cardiac endothelial cells.
  Ottaviani L, Juni RP, de Abreu RC, Sansonetti M, Sampaio-Pinto V, Halkein J, Hegenbarth JC, Ring N, Knoops K, Kocken JMM, Jesus C, Ernault AC, El Azzouzi H, Rühle F, Olieslagers S, Fernandes H, Ferreira L, Braga L, Stoll M, Nascimento DS, de Windt LJ, da Costa Martins PA. Ottaviani L, et al. Mol Ther. 2022 Jun 1;30(6):2257-2273. doi: 10.1016/j.ymthe.2022.03.002. Epub 2022 Mar 9. Mol Ther. 2022. PMID: 35278675 Free PMC article.
• Ceramide in stress response.
  Nikolova-Karakashian MN, Rozenova KA. Nikolova-Karakashian MN, et al. Adv Exp Med Biol. 2010;688:86-108. doi: 10.1007/978-1-4419-6741-1_6. Adv Exp Med Biol. 2010. PMID: 20919648 Free PMC article. Review.
• The neutral sphingomyelinase family: identifying biochemical connections.
  Clarke CJ, Wu BX, Hannun YA. Clarke CJ, et al. Adv Enzyme Regul. 2011;51(1):51-8. doi: 10.1016/j.advenzreg.2010.09.016. Epub 2010 Oct 28. Adv Enzyme Regul. 2011. PMID: 21035485 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Molecular Biology Databases

  • BioCyc
  • GlyGen glycoinformatics resource